Analysts’ Perspective: Airgain (AIRG), Sanofi (SNY), Belmond (BEL)

Investment Analysts at B. Riley FBR upgraded Airgain, Inc. (NASDAQ:AIRG) shares from Neutral to Buy rating while increasing their price target from $8.50 to $13.

Airgain, Inc. designs, develops, and engineers antenna products for original equipment and design manufactures, chipset vendors, and service providers worldwide.


Brokerage Firm Citigroup upgraded Sanofi (NYSE:SNY) shares from Neutral to Buy rating.

Sanofi provides therapeutic solutions.


Belmond Ltd. (NYSE:BEL) shares were upgraded by analysts at Jefferies from Hold to Buy rating.

Belmond Ltd. engages in the hotel and travel businesses.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at